Gut Microbiota–Medication Interaction in Rheumatic Diseases
Besides its contribution to the development of rheumatic diseases, the gut microbiota interact with anti-rheumatic drugs. The intestinal microbiota can directly metabolize many drugs and indirectly change drug metabolism through a complex multi-dimensional interaction with the host, thus affecting i...
Guardado en:
Autores principales: | Lingshu Zhang, Cong-Qiu Chu |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1a0d74486ac34616b400640b8bd8e5f4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Efficacy and safety of various anti-rheumatic treatments for patients with rheumatoid arthritis: a network meta-analysis
por: Kexun Ma, et al.
Publicado: (2018) -
Prevalence and clinical characteristics of rheumatoid arthritis in Poland: a nationwide study
por: Bogdan Batko, et al.
Publicado: (2018) -
Correlation between HLA haplotypes and the development of antidrug antibodies in a cohort of patients with rheumatic diseases
por: Benucci M, et al.
Publicado: (2018) -
Rheumatological aspects of pathogenesis and treatment of COVID-19 infection
por: Desislava Kalinova, et al.
Publicado: (2020) -
Rheumatic fever: New ideas in diagnosis and management
por: John Lawrenson
Publicado: (2017)